Literature DB >> 20352141

Screening patients for primary prophylaxis implantable cardioverter defibrillators: insights into current practices.

Pablo B Nery, Nisha D'Mello, Rob Beanlands.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20352141      PMCID： PMC2851475          DOI： 10.1016/s0828-282x(10)70359-7

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN： 0828-282X            Impact factor:   5.223


× No keyword cloud information.
  24 in total

Review 1.  Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada.

Authors:  Anthony S Tang; Heather Ross; Christopher S Simpson; L Brent Mitchell; Paul Dorian; Ron Goeree; Barry Hoffmaster; Malcolm Arnold; Mario Talajic
Journal:  Can J Cardiol       Date:  2005-05       Impact factor: 5.223

2.  Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group.

Authors:  R Jaeschke; G H Guyatt; D L Sackett
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

3.  Left ventricular ejection fraction: comparison of results from planar and SPECT gated blood-pool studies.

Authors:  M L Bartlett; G Srinivasan; W C Barker; A N Kitsiou; V Dilsizian; S L Bacharach
Journal:  J Nucl Med       Date:  1996-11       Impact factor: 10.057

4.  Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions.

Authors:  N van Royen; C C Jaffe; H M Krumholz; K M Johnson; P J Lynch; D Natale; P Atkinson; P Deman; F J Wackers
Journal:  Am J Cardiol       Date:  1996-04-15       Impact factor: 2.778

5.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

6.  Correspondence of left ventricular ejection fraction determinations from two-dimensional echocardiography, radionuclide angiography and contrast cineangiography.

Authors:  M M Naik; G A Diamond; T Pai; A Soffer; R J Siegel
Journal:  J Am Coll Cardiol       Date:  1995-03-15       Impact factor: 24.094

7.  The reproducibility of radionuclide angiographic measurements of left ventricular function in normal subjects at rest and during exercise.

Authors:  M T Upton; S K Rerych; G E Newman; E P Bounous; R H Jones
Journal:  Circulation       Date:  1980-07       Impact factor: 29.690

Review 8.  Analysis of left ventricular systolic function.

Authors:  N B Schiller; E Foster
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

9.  Determination of left ventricular ejection fraction using intravenous contrast and a semiautomated border detection algorithm.

Authors:  Eric H c Yu; Danny M Skyba; Cairrine E Sloggett; Michal Jamorski; R Mark Iwanochko; Bryan F Dias; Harry Rakowski; Samuel C Siu
Journal:  J Am Soc Echocardiogr       Date:  2003-01       Impact factor: 5.251

10.  Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging.

Authors:  W G Hundley; A M Kizilbash; I Afridi; F Franco; R M Peshock; P A Grayburn
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.